Menu
Back to User profile » Professor Mike Thomas
Papers published by Professor Mike Thomas:
Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data
Anderson M, Collison K, Drummond MB, Hamilton M, Jain R, Martin N, Mularski RA, Thomas M, Zhu CQ, Ferguson GT
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:933-943
Published Date: 12 April 2021
Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
Harries TH, Gilworth G, Corrigan CJ, Murphy PB, Hart N, Thomas M, White PT
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:3063-3066
Published Date: 3 January 2020
Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey
Gruffydd-Jones K, Thomas M, Roman-Rodríguez M, Infantino A, FitzGerald JM, Pavord I, Haddon JM, Elsasser U, Vogelberg C
Journal of Asthma and Allergy 2019, 12:183-194
Published Date: 11 July 2019
Independent determinants of disease-related quality of life in COPD – scope for nonpharmacologic interventions?
Brien SB, Stuart B, Dickens AP, Kendrick T, Jordan RE, Adab P, Thomas M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:247-256
Published Date: 9 January 2018
When is dual bronchodilation indicated in COPD?
Thomas M, Halpin DMG, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2291-2305
Published Date: 3 August 2017
Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records
Williams NP, Coombs NA, Johnson MJ, Josephs LK, Rigge LA, Staples KJ, Thomas M, Wilkinson TMA
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:313-322
Published Date: 17 January 2017
Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review
Price D, Østrem A, Thomas M, Welte T
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:141-168
Published Date: 30 December 2016
Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice
Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C
Journal of Asthma and Allergy 2016, 9:1-12
Published Date: 7 January 2016
Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
Price D, Kaplan A, Jones R, Freeman D, Burden A, Gould S, von Ziegenweidt J, Ali M, King C, Thomas M
Journal of Asthma and Allergy 2015, 8:1-13
Published Date: 14 January 2015
Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease
Brockwell C, Ampikaipakan S, Sexton DW, Price D, Freeman D, Thomas M, Ali M, Wilson AM
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:715-721
Published Date: 9 July 2014
Physicians’ attitudes towards combination therapy with inhaled corticosteroids and long-acting ß2-agonists: an observational study in UK specialist care
Thomas M, Haughney J, Price D
Pragmatic and Observational Research 2011, 2:25-31
Published Date: 16 December 2011